VELOXIS PHARMACEUTICALS A/S
CVR 26527767 · Public limited company (A/S) · Active · Medium risk
VELOXIS PHARMACEUTICALS A/S is a Public limited company (A/S), founded on , based in Nordhavn. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 1.6% over the next 12 months, which is 1.1 times the average for Danish companies. 20 annual reports have been published, of which 5 more than six months after the end of the financial year.
Bankruptcy risk for VELOXIS PHARMACEUTICALS A/S
1.6%
probability of bankruptcy within 12 months
Medium risk
1.1 × the average (1.41%) · higher risk than 79% of active Danish companies
Lowest riskHighest risk
Increases the risk
Number of CEOs0 · bankruptcy rate 12.7%1.4×
Website registeredYes · bankruptcy rate 12.0%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Other companies at the same address100+ · bankruptcy rate 11.5%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×
Municipality changes3+ · bankruptcy rate 10.6%1.2×
Employees (latest year)2–5 · bankruptcy rate 10.3%1.2×
Postcode changes3+ · bankruptcy rate 10.2%1.2×
Reduces the risk
Auditor's statementAndet · bankruptcy rate 0.0%0.00×
Age (years)20+ yrs · bankruptcy rate 2.0%0.23×
Published annual reports10+ · bankruptcy rate 3.0%0.35×
Reporting classReporting class B · bankruptcy rate 3.2%0.37×
Number of auditors (historical)3+ · bankruptcy rate 3.7%0.42×
CEOs in total (historical)5+ · bankruptcy rate 3.8%0.43×
Company typeA/S · bankruptcy rate 4.4%0.50×
Share of late annual reports0.01%–25% · bankruptcy rate 4.5%0.51×
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 26527767
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (24 years)
- Address
- c/o Bech-Bruun, Gdanskgade 18
2150 Nordhavn - Municipality
- København
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 686.4m
- Employees
- 2 (2018)
- Auditor
- PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 5 of 24 |
| Missing annual report | No |
| Negative equity | – |
| Equity ratio | – |
| Current ratio | – |
| Moves (last 2 years) | 0 |
| CEO changes in total | 21 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 276 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2026 | 2025 |
|---|---|---|
| Avg. employees | 1 | 1 |
Latest annual report: Reporting class B · auditor's statement: Independent Auditor’s Report · PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Apr 2025 – 31 Mar 2026 | 197 | Late | |
| 1 Apr 2024 – 31 Mar 2025 | 199 | Late | |
| 1 Apr 2023 – 31 Mar 2024 | 219 | Late | |
| 1 Apr 2022 – 31 Mar 2023 | 189 | Late | |
| 1 Apr 2021 – 31 Mar 2022 | 162 | ||
| 1 Apr 2020 – 31 Mar 2021 | 153 | ||
| 1 Jan 2019 – 31 Mar 2020 | 153 | ||
| 1 Jan 2018 – 31 Dec 2018 | 99 | ||
| 1 Jan 2017 – 31 Dec 2017 | 121 | ||
| 1 Jan 2016 – 31 Dec 2016 | 108 | ||
| 1 Jan 2015 – 31 Dec 2015 | 102 | ||
| 1 Jan 2014 – 31 Dec 2014 | 86 | ||
| 1 Jan 2013 – 31 Dec 2013 | 139 | ||
| 1 Jan 2012 – 31 Dec 2012 | 114 | ||
| 1 Jan 2011 – 31 Dec 2011 | 117 | ||
| 1 Jan 2010 – 31 Dec 2010 | 108 | ||
| 1 Jan 2009 – 31 Dec 2009 | 115 | ||
| 1 Jan 2008 – 31 Dec 2008 | 154 | ||
| 1 Jan 2007 – 31 Dec 2007 | 143 | ||
| 1 Jan 2006 – 31 Dec 2006 | 210 | Late |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Klaus Søgaard | ||
| CEO | Tomas Norling | ||
| CEO | Michael Wolff Jensen | ||
| CEO | Hans Christian Eberhard Groth Teisen | ||
| CEO | Peter Gudmund Nielsen | ||
| CEO | Michael Beckert | ||
| CEO | Karin Jexner Hamberg | ||
| CEO | Johnny Stilou | ||
| CEO | Alastair Stuart McEwan | ||
| CEO | Morten Marott | ||
| CEO | Ira Duarte | ||
| Board | Daisuke Matsuo | Current | |
| Board | Keigo Nakatsukasa | Current | |
| Board | Kenro Yuzaki | Current | |
| Board | Klaus Søgaard | ||
| Board | Jan-Erik Gunnar Svensson | ||
| Board | Troels Elkiær Andersen | ||
| Board | Florian Schønharting | ||
| Board | Ole Vahlgren | ||
| Board | Anders Buur | ||
| Board | Jean Joachim Deleage | ||
| Board | Flemming Ørnskov | ||
| Board | Gaston Georges Gerard Soula | ||
| Board | Kurt Anker Nielsen | ||
| Board | Claus Tycho Bræstrup | ||
| Board | Anders Götzsche | ||
| Board | Paul Edick | ||
| Board | Thomas Peter Dyrberg | ||
| Board | Mette Kirstine Agger | ||
| Board | Kim Bjørnstrup | ||
| Board | Edward Etienne Penhoet | ||
| Board | Mette Kirstine Agger | ||
| Board | Michael Thomas Heffernan | ||
| Board | Mette Kirstine Agger | ||
| Board | Thomas Peter Dyrberg | ||
| Board | Michael Thomas Heffernan | ||
| Board | Lars Kåre Viksmoen | ||
| Board | Paul Kevin Wotton | ||
| Board | Robert Samuel Radie | ||
| Board | Masaya Etoh | ||
| Board | Matthew Ryan Dumont | ||
| Board | Masaya Etoh | ||
| Board | Hideo Hikami | ||
| Board | Hiroki Ideguchi | ||
| Board | Yusuke Hiramatsu | ||
| Owner (100%) | Asahi Kasei Corporation | Current | |
| Owner (33%) | LUNDBECKFOND INVEST A/S | ||
| Owner (33%) | Novo Holdings A/S | ||
| Owner (90%) | Asahi Kasei Pharma Denmark A/S | ||
| Owner (100%) | Asahi Kasei Pharma Denmark A/S | ||
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | Current | |
| Auditor | DELOITTE STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | PricewaterhouseCoopers, Statsautoriseret Revisionsinteressentskab | ||
| Auditor | PRICEWATERHOUSECOOPERS SERVICES STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Founder | GORRISSEN FEDERSPIEL KOMPLEMENTAR ADVOKATANPARTSSELSKAB | Current |
The CEOs' other companies
Klaus Søgaard – 31 other companies, of which 31 bankrupt
- 1EEUROPE DENMARK A/S Bankrupt 24 Jul 2001
- ACT IT A/S Bankrupt 23 Aug 2010
- AFVIKLINGSSELSKABET I AF 19. AUGUST 2004 A/S Bankrupt 5 Nov 2004
- AJOURIT A/S Bankrupt 27 Mar 2002
- ANECO ApS Bankrupt 18 Mar 2011
- BERENDTSEN FOOD A/S Bankrupt 13 Nov 2008
- BETTER PLACE DANMARK A/S Bankrupt 28 May 2013
- BIO FUND MANAGEMENT A/S Bankrupt 25 Jan 2012
- BLANKENBURG A/S Bankrupt 16 Nov 2007
- BON CONSULT ApS Bankrupt 6 Feb 2018
- BRA-KLO A/S Bankrupt 12 Apr 1994
- COMPUTER GIANTS (DENMARK) ApS Bankrupt 22 Nov 2005
- CONVERTIBLE ApS Bankrupt 30 Aug 2002
- DANSK LOKOMOTIVFØRER SERVICES A/S Bankrupt 20 Jan 2009
- DENTALMAN INTERNATIONAL A/S Bankrupt 4 Feb 2002
- DRIFTSSELSKAB AF 16. APRIL 2009 A/S Bankrupt 20 Apr 2009
- E-SENSE A/S Bankrupt 17 May 2005
- E2233 LEASING ApS Bankrupt 23 Nov 2023
- ENERGY SERVICES ApS Bankrupt 11 Mar 2009
- FLASKECENTRALEN ApS Bankrupt 30 Sep 1997
- FLEXATEL COMMMUNICATION A/S Bankrupt 13 Jun 2006
- GOLDEN TULIP HOSPITALITY MANAGEMENT DENMARK ApS Bankrupt 19 Nov 2009
- GV HOLDING ApS Bankrupt 2 Feb 1996
- HARVEST MOON HOLDING ApS Bankrupt 18 Nov 2013
- HENRIK DYRING ApS Bankrupt 5 Mar 2008
- HOLDINGSELSKAB AF 16. APRIL 2009 A/S Bankrupt 30 Sep 2009
- HVR ApS Bankrupt 25 Oct 2024
- ICON MEDIALAB A/S Bankrupt 28 Aug 2003
- ISENSUS ApS Bankrupt 20 Apr 2016
- IT FACTORY A/S Bankrupt 1 Dec 2008
Tomas Norling – 2 other companies
- PHARMAERO ApS Opløst
- TNO HOLDING ApS Opløst
Michael Wolff Jensen – 21 other companies, of which 6 bankrupt
- EMF ENVIROTEC A/S Bankrupt 24 Mar 2010
- NETWORKLEAGUE A/S Bankrupt 31 Jan 2002
- PARADIS INTERNATIONAL A/S Bankrupt 24 May 2023
- PDK A/S Bankrupt 2 Mar 2023
- TOUCHDIVA EUROPE A/S Bankrupt 26 Mar 2010
- UNWIREDFACTORY A/S Bankrupt 19 Feb 2004
- ASCENDIS PHARMA A/S Active
- ASCENDIS PHARMA BONE DISEASES A/S Active
- ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S Active
- AZANTA A/S Active
- Ascendis Pharma Endocrinology Division A/S Active
- Ascendis Pharma Europe A/S Active
- Ascendis Pharma Growth Disorders A/S Active
- Ascendis Pharma Nordics A/S Opløst
- Ascendis Pharma Oncology Division A/S Active
- Custimoo ApS Active
- EMF INDUSTRIES A/S Compulsorily dissolved
- GENMAB A/S Active
- PARADIS GROUP ApS Fusioneret
- TECH GROWTH INVEST ApS Active
- VANX ApS Opløst
Hans Christian Eberhard Groth Teisen – 22 other companies
- Astrup Gods A/S Active
- BLUEPIPE A/S Active
- CHATEF ApS Active
- DPCT Holding ApS Active
- DynamicsPrint ApS Active
- GREEN PRODUCT A/S Active
- Green IV ApS Opløst
- HANDELSSELSKABET AF 5. JANUAR 2002 A/S Opløst
- OMPAKNINGSSELSKABET AF 1. NOVEMBER 2005 A/S Opløst
- ORIFARM A/S Active
- ORIFARM DISTRIBUTION A/S Opløst
- ORIFARM GENERICS A/S Active
- ORIFARM GENERICS HOLDING A/S Active
- ORIFARM GROUP A/S Active
- ORIFARM PROPERTY A/S Active
- ORIFARM SUPPLY A/S Active
- SIGMARISKPARTNERS ApS Opløst
- SKOVDYRKERNE FYN - PRODUKTION ApS Active
- TTIT A/S Active
- TTIT EJENDOMME A/S Active
- TTIT Landbrug A/S Active
- Tietgen Invest ApS Active
Peter Gudmund Nielsen – 4 other companies
- Helida Holding ApS Active
- Helida Invest ApS Fusioneret
- MLMC Therapeutics ApS Active
- ONCORAL PHARMA ApS Active
Karin Jexner Hamberg – 3 other companies
- LEO Holding A/S Active
- QSI PHARMA A/S Opløst
- THROMBOLOGIC ApS Opløst
Johnny Stilou – 9 other companies
- HVISSINGE PARK ApS Opløst
- JoSe ApS Active
- Lugano Ejendomme A/S Active
- NETTEST (DENMARK) A/S Opløst
- NETTEST FINANS A/S Opløst
- NUEVOLUTION A/S Active
- SANIONA A/S Active
- Stilou Studio ApS Opløst
- Travel4Business ApS Active
Address history (9 moves)
| c/o Bech-Bruun, Gdanskgade 18, 2150 Nordhavn | |
| c/o Bech-Bruun, Langelinie Allé 35, 2100 København Ø | |
| c/o Plesner Advokatfirma, Amerika Plads 37, 2100 København Ø | |
| Agern Alle 24, 4. 2, 2970 Hørsholm | |
| Bøge Alle 5, 2. th, 2970 Hørsholm | |
| Kogle Alle 4, 2970 Hørsholm | |
| Kogle Alle 4, 2970 Hørsholm | |
| Carl Jacobsens Vej 22, 2500 Valby | |
| Ottiliavej 9, 2500 Valby | |
| c/o Gorissen Federspiel Kirkegaard, H.C. Andersens Boulevard 12, 1553 København V |
Former names
| VELOXIS PHARMACEUTICALS A/S | – now |
| LIFECYCLE PHARMA A/S | – |
| PHAROTECH A/S | – |
| GFKJURA 935 A/S | – |
Employees per year
Other companies at the same address
- ADVOKATANPARTSSELSKABET J. PETERSEN Active
- AK Valhalla Denmark Bidco ApS Active
- AKTIESELSKABET CASINO EJENDOMSSELSKAB Active
- ASEN 2 ApS Active
- ASEN 3 ApS Active
- ASEN 4 ApS Active
- ATKL Brasiliana GP ApS Active
- Aktieselskabet af 27.04.1999 Opløst
- America Europe Connect 2 Denmark ApS Active
- Anpartsselskabet af 20. juni 2023 Active
- Aqua Comms Denmark ApS Active
- Asahi Kasei Pharma Denmark A/S Active
- Asen 1 ApS Opløst
- Asen 5 ApS Active
- Asen 6 ApS Active
- Asen 7 ApS Active
- Asen 8 ApS Active
- Asen 9 ApS Active
- Asen Holding 1 ApS Active
- Asen Holding 2 ApS Active
- Asen Holding 3 ApS Active
- Asen Holding 5 ApS Active
- Asen Holding 6 ApS Active
- Atreides Caseri Denmark ApS Active
- BGM-CO GP ApS Active
Similar companies in København
- AffiCon ApS Valby
- EXTITUTION ApS København Ø
- Coco Sense ApS København NV
- Everllence Denmark A/S København SV
- BioSpectre ApS København V
- Nordic Cell Therapy Group ApS København N
- FiberSure ApS København Ø
- Tasira ApS København N
- Xenogen ApS København S
- Magnalev Core ApS København SV
- Pin Joint ApS København S
- Maglya ApS København Ø
Questions and answers about VELOXIS PHARMACEUTICALS A/S
Has VELOXIS PHARMACEUTICALS A/S gone bankrupt?
No, VELOXIS PHARMACEUTICALS A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of VELOXIS PHARMACEUTICALS A/S?
Our model estimates a bankruptcy risk of 1.6% over the next 12 months (medium risk), which is 1.1 times the average for Danish companies.
Who is the auditor of VELOXIS PHARMACEUTICALS A/S?
VELOXIS PHARMACEUTICALS A/S most recently used PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB.
When was VELOXIS PHARMACEUTICALS A/S founded?
VELOXIS PHARMACEUTICALS A/S was founded on 21 March 2002.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.